Studying drug resistance in Aspergillus lung infections
Part of Infections clinical trials.
This study looks at samples from your lungs that contain Aspergillus fungus to understand why some fungi become resistant to antifungal medicines. By joining, you help researchers find better ways to treat these infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must agree to take part in the study and sign a consent form.
- You must be covered by French social security (health insurance).
- You must have had a respiratory sample (like sputum or a lung wash) between 2020 and now that tested positive for Aspergillus fungus.
- You must live in the Loire-Atlantique or Vendée areas of France.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of inhaled liposomal amphotericin B (Ambisome) plus itraconazole works better for chronic pulmonary aspergillosis (CPA). It may help control long-term Aspergillus lung infection and symptoms.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
This study aims to detect invasive lung aspergillosis earlier by testing samples from your lungs and measuring specific lab markers. It may help doctors start the right antifungal treatment sooner when the infection is suspected.
This study looks at whether repeated PCR tests for a fungus called Aspergillus fumigatus (in blood or lung fluid) can help doctors track how well treatment is working for a serious lung infection called invasive aspergillosis. It is for people who already had a positive PCR test at diagnosis.
This study looks at how chronic pulmonary aspergillosis (a long-term lung infection) affects your daily life, health, and overall well-being. By joining, you'll help researchers understand what it's like to live with this condition.
This study looks at how the presence of fungus in lung samples relates to the long-term outlook for people with allergic bronchopulmonary aspergillosis (ABPA). It aims to help doctors better understand the disease and guide treatment.
Hear when a new Aspergillus Fumigatus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.